Amarin continues rebound, up 3%
Amarin Corp. ADR
WKN: A0NBNG / Symbol: AMRN / Name: Amarin / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /
0,53 €
0,92 %
Amarin (AMRN +3.4%) continues to claw back from its extended FDA action date-stoked selloff a couple of weeks ago. Shares have rallied 16% since touching $13.76 on August 12.
This morning, ROTH Capital reiterated its Buy rating and $31 (94% upside) price target.
This morning, ROTH Capital reiterated its Buy rating and $31 (94% upside) price target.
Neueste Beiträge
RudolfL in K+S AG diskutieren, K+S AG